Related Experiment Video
Updated: Jun 20, 2026

16:19
Fluorescence in situ hybridization (FISH) Protocol in Human Sperm
Published on: September 1, 2009
Fluorescence in situ hybridization (FISH) protocol in human sperm
1Unitat de Biologia Cellular (Facultat de Biociències).
Journal of Visualized Experiments : Jove
|September 3, 2009
Summary
Sperm fluorescence in situ hybridization (FISH) analyzes numerical chromosome abnormalities in sperm, crucial for assessing risks of transmitting aneuploidies to offspring. This method aids clinical diagnosis in genetic reproductive counseling.
Area of Science:
- Human genetics
- Reproductive biology
- Cytogenetics
Background:
- Aneuploidies, frequent human chromosomal abnormalities, often stem from parental meiotic errors.
- Male meiotic errors can produce spermatozoa with numerical chromosome abnormalities, increasing offspring anomaly transmission risk.
- Sperm fluorescence in situ hybridization (FISH) is a key diagnostic tool for assessing these risks.
Purpose of the Study:
- To provide a detailed, step-by-step protocol for performing sperm FISH analysis.
- To guide clinicians in processing semen samples for accurate FISH preparations.
- To enhance the understanding and application of sperm FISH in clinical reproductive genetics.
Main Methods:
- Detailed description of human semen sample processing and fixation.
- Step-by-step chromatin decondensation and denaturation procedures for sperm.
- Methodology for obtaining sperm FISH preparations and microscopic visualization.
Main Results:
- The video-article demonstrates the practical application of sperm FISH.
- It highlights critical steps for optimizing sperm FISH slide preparation and analysis.
- Focuses on the analysis of chromosomes X, Y, 13, 18, and 21 in human spermatozoa.
Conclusions:
- Sperm FISH is an established protocol for estimating numerical chromosome abnormalities in sperm.
- Accurate sample preparation and analysis are vital for reliable clinical diagnostic results.
- This protocol supports genetic reproductive counseling by assessing aneuploidy risks.

